BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37055906)

  • 1. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors.
    Morgan AD; Ramai D; Bandaru P; Crino SF; Facciorusso A
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1355-1358. PubMed ID: 37055906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
    Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
    Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and predictive factors of endoscopic ultrasound-guided ethanol ablation in benign solid pancreatic tumors.
    Choi JH; Paik WH; Lee SH; Lee MW; Cho IR; Ryu JK; Kim YT
    Surg Endosc; 2023 Aug; 37(8):5960-5968. PubMed ID: 37079095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    Kawasaki Y; Hijioka S; Nagashio Y; Maruki Y; Ohba A; Takeshita K; Takasaki T; Agarie D; Hagiwara Y; Hara H; Okamoto K; Yamashige D; Kondo S; Morizane C; Ueno H; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Tamada K; Hiraoka N; Saito Y; Okusaka T
    J Gastroenterol; 2023 Jul; 58(7):693-703. PubMed ID: 37154933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
    Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors.
    Rustagi T; Farrell JJ
    J Clin Gastroenterol; 2014; 48(10):837-44. PubMed ID: 24828360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of the role of endoscopy in evaluation and management of gastrointestinal and pancreatic neuroendocrine tumors.
    Nabi Z; Lakhtakia S; Reddy DN
    Indian J Gastroenterol; 2023 Apr; 42(2):158-172. PubMed ID: 37129761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors.
    Oleinikov K; Dancour A; Epshtein J; Benson A; Mazeh H; Tal I; Matalon S; Benbassat CA; Livovsky DM; Goldin E; Gross DJ; Jacob H; Grozinsky-Glasberg S
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2637-2647. PubMed ID: 31102458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
    Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
    Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review.
    Dhar J; Samanta J; Nabi Z; Aggarwal M; Facciorusso A; Conti Bellocchi MC; Crinò SF
    Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):37-53. PubMed ID: 38383965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
    So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
    Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound-guided therapies in pancreatic neoplasms.
    Yang D; DiMaio CJ
    Biomed Res Int; 2015; 2015():731049. PubMed ID: 25802863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUS-guided fine needle tattooing (EUS-FNT) for preoperative localization of small pancreatic neuroendocrine tumors (p-NETs): a single-center experience.
    Rosa F; Rimbaș M; Rizzatti G; Quero G; Fiorillo C; Impagnatiello M; D'Aversa F; Costamagna G; Alfieri S; Larghi A
    Surg Endosc; 2021 Jan; 35(1):486-492. PubMed ID: 32959183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
    Tamagno G; Scherer V; Caimo A; Bergmann SR; Kann PH
    Digestion; 2018; 98(2):112-118. PubMed ID: 29698969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Ultrasound-Guided Local Ablative Therapies for the Treatment of Pancreatic Neuroendocrine Tumors and Cystic Lesions: A Review of the Current Literature.
    Prete AM; Gonda TA
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
    Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
    Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ablation therapy for the pancreatic neoplasms.
    Matsumoto K; Kato H
    Dig Endosc; 2023 May; 35(4):430-442. PubMed ID: 36366955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours.
    Alsohaibani F; Bigam D; Kneteman N; Shapiro AM; Sandha GS
    Can J Gastroenterol; 2008 Oct; 22(10):817-20. PubMed ID: 18925304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
    Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
    Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis.
    Sirtl S; Mahajan UM; Auernhammer CJ; Dziadkiewicz P; Hohmann E; Wójcik M; Kos-Kudła B; Hartleb M; Knösel T; Schirra J; Mayerle J; Schulz C; Żorniak M
    Pancreatology; 2022 Jun; 22(5):644-650. PubMed ID: 35589512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.